Evaluation of tumor responses and overall survival in recurrent glioblastoma (GBM) patients from a Phase IIa trial of a CMV vaccine immunotherapeutic candidate (VBI-1901)

Conference: 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Date: June 6, 2022